| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/27/2007 | US7183116 Methods for isolation and labeling of sample molecules |
| 02/27/2007 | US7183114 Determining the concentration and ratio of carbon monoxide to carbon dioxide in the gaseous product of a fluidized bed reactor for producing titanium tetrachloride using infrared analysis |
| 02/27/2007 | US7183113 Providing a support carrying substances to be tested, coating the support with a suspension containing luminescent microorganisms, detecting the change in luminescence (luminescence is stimulated during or before detection) |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |
| 02/27/2007 | US7183111 Immunomodulatory formulations and methods for use thereof |
| 02/27/2007 | US7183105 Eubacterial minicells and their use as vectors for nucleic acid delivery and expression |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7183099 Autoinducer is not an acyl-homoserine lactone and can interact with the Vibrio harveyi LuxQ protein, increasing expression of the operon; drug screening |
| 02/27/2007 | US7183095 Cell culture system for synthesis of infectious hepatitis C virus |
| 02/27/2007 | US7183085 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
| 02/27/2007 | US7183084 Method for the determination of a nucleic acid using a control |
| 02/27/2007 | US7183081 Nucleotide sequences coding cytokine polypeptide for use in identifying modulator for treatment or arthritis, allergies, infections, inflammation, skin and cell proliferative disorders; wound healing agents |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7183075 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 02/27/2007 | US7183072 Despositing metal on surface; obtain metal particle, conjugate to enzyme substrate, incubate with enzyme, evaluate surface for metal deposition |
| 02/27/2007 | US7183071 Anthrax lethal factor is a MAPK kinase protease |
| 02/27/2007 | US7183069 Chromogen modified oligosaccharide for monitoring hydrolase activity and diagnosing pancreatic, tumor, kidney or liver disorders |
| 02/27/2007 | US7183068 For use in ionophoretic devices; glucose oxidoreductases; mutarotases |
| 02/27/2007 | US7183067 Versatile linker compound, ligand, and producing method thereof |
| 02/27/2007 | US7183066 Comprises substrate composition for detecting presence of tetanus and botulinum toxoids in neuronal tissues; food poisoning |
| 02/27/2007 | US7183065 Diagnosing ulcerative colitis in humans; obtain sample tissue, incubate with histone antigen, detect presence of complex formation, presence of complex indicates ulcerative colitis |
| 02/27/2007 | US7183064 increase or decrease in the intensity of the P2X purinergic receptor expression profile in the prostate or breast cells respectively compared to the expression profile of a normal subject, is diagnostic of the presence of breast cancer |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7183062 Prostaglandin receptor protein and methods of use thereof |
| 02/27/2007 | US7183061 Comprises nucleotide sequences coding heliothis ecdysone receptor for controlling gene transcrption in transgenic animal models |
| 02/27/2007 | US7183060 specific synthetic peptide sequences derived from E. ewingii that can be used in place of purified proteins, partially purified proteins, infected cells, or cell lysates from Ehrlichia species other than E. ewingii |
| 02/27/2007 | US7183059 Selecting desired synthetic precursors having defined stereochemical relationships, reacting precursors to obtain compound having specific stereochemistry, repeating selecting and reacting until desired library is obtained |
| 02/27/2007 | US7183057 applying an adhesive tape to a target area of the skin in a manner sufficient to isolate an epidermal sample adhering to the adhesive tape, wherein the epidermal sample comprises nucleic acid molecules; and detecting expression of the nucleic acid molecules in the epidermal sample |
| 02/27/2007 | US7183054 Glyceraldehyde-3-phosphate dehydrogenase and Saframycin A/dna complexes; evaluation of microbiocidal and antiproliferative activity |
| 02/27/2007 | US7183051 Diagnosis and treatment of cancer |
| 02/27/2007 | US7183050 Surface with an immobilized layer for use as diagnostic and detetion tool in genetic engineering |
| 02/27/2007 | US7183046 Human polypeptide for use as an antitumor agent |
| 02/27/2007 | US7182946 monoclonal antibody produced by the hybridoma cell line 57D2, deposited in accordance with the Budapest treaty under the number DSM ACC2568, or a fragment of |
| 02/27/2007 | US7182916 Method and the device for micro-particle array fabrication |
| 02/27/2007 | US7182915 Pipette configurations and arrays thereof for measuring cellular electrical properties |
| 02/27/2007 | US7182913 Accuracy |
| 02/27/2007 | US7182911 analysis apparatus used for measuring analyzing concentration of predetermined chemical components in a sample of liquids such as blood or urine |
| 02/27/2007 | US7182910 Apparatus for collecting, testing and monitoring blood glucose levels |
| 02/27/2007 | US7182853 Detecting preferential particles in sample; generate redox system, provide control, analyze sample using electrochemical, spectroscopic, radioimmunoassays or magnetic field platforms |
| 02/27/2007 | US7182509 Nanoliter osmometer and method of operation |
| 02/27/2007 | US7182338 Apparatus for discriminating sheet material |
| 02/27/2007 | US7181978 Method, apparatus and system for forecasting strength of cementitious material |
| 02/27/2007 | US7181955 Apparatus and method for measuring multi-Phase flows in pulp and paper industry applications |
| 02/27/2007 | US7181952 Characterization of mist sprays using a phase-doppler particle analyzer and an iso-kinetic sampling probe |
| 02/27/2007 | CA2352571C In vivo biosensor apparatus and method of use |
| 02/27/2007 | CA2286335C Methods of obtaining antigens specific for fungi, antibodies for such antigens, and diagnosis of disease using such antigens and/or antibodies |
| 02/27/2007 | CA2098253C Method for producing ectoprotein of hepatitis c virus |
| 02/25/2007 | CA2517218A1 Marker for psychosis or mood disorder |
| 02/22/2007 | WO2007022543A2 Methods and kits for distinguishing between specific and non-specific protein associations |
| 02/22/2007 | WO2007022507A2 Apparatus and method for determining the amount of time until a desired temperature is reached |
| 02/22/2007 | WO2007022485A2 Sterilization of biosensors |
| 02/22/2007 | WO2007022475A1 Fas binding antibodies |
| 02/22/2007 | WO2007022436A2 Hematopoietic cell phenotyping using circulating cell-free markers |
| 02/22/2007 | WO2007022346A2 Cellular function underlying bone micro-structure characteristic of type 2 diabetes |
| 02/22/2007 | WO2007022248A2 Methods of detection of cancer using peptide profiles |
| 02/22/2007 | WO2007022215A2 Method for test strip manufacturing and analysis |
| 02/22/2007 | WO2007022214A2 Apoptosis sensivity to ap02l/trail by testing for galnac-t14 expression in cells/tissues |
| 02/22/2007 | WO2007022172A1 Human monoclonal antibodies that specifically bind igf-ii |
| 02/22/2007 | WO2007022157A2 Apoptosis sensitivity to ap02l/trail by testing for 'galnac-t14 expression in cells/tissues |
| 02/22/2007 | WO2007022089A2 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products |
| 02/22/2007 | WO2007022086A2 Antibodies and methods for predicting dental caries |
| 02/22/2007 | WO2007022074A2 Assay particles and methods of use |
| 02/22/2007 | WO2007022043A2 Method of measuring the biological activity of an urotensin ii receptor |
| 02/22/2007 | WO2007022015A1 Methods to evaluate amyloid beta-lowering agents using wild-type mice |
| 02/22/2007 | WO2007021953A2 Measurement of distributed total acid numbers of a hydrocarbon feedstream by electrospray mass spectrometry |
| 02/22/2007 | WO2007021860A2 QUANTITATIVE ASSAYS FOR PDGFR-β IN BODY FLUIDS |
| 02/22/2007 | WO2007021853A2 Neuregulin1-stimulated cell adhesion and cell migration |
| 02/22/2007 | WO2007021841A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 02/22/2007 | WO2007021825A2 Treatment of proliferative disorders |
| 02/22/2007 | WO2007021757A2 Fluorescent sensor and methods |
| 02/22/2007 | WO2007021628A2 Target and assay for lead compounds for polycystic kidney disease |
| 02/22/2007 | WO2007021501A1 Improvements to protein arrays |
| 02/22/2007 | WO2007021255A1 Antibodies to alpha-synuclein |
| 02/22/2007 | WO2007021251A1 An arrangement for a selection of a wavelength |
| 02/22/2007 | WO2007021211A1 Method for diagnosticating human tumoral diseases |
| 02/22/2007 | WO2007021016A1 Photoregulated peptide, and method for regulation of peptide-protein complex formation using the photoregulated peptide |
| 02/22/2007 | WO2007021004A1 Msx1/2, MARKERS OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007021003A1 Nato3, MARKER OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON |
| 02/22/2007 | WO2007021002A1 Immunodetection method for influenza virus h5 subtype |
| 02/22/2007 | WO2007020989A1 Sulfate adenyltransferase gene and use thereof |
| 02/22/2007 | WO2007020965A1 Method of inhibiting function of cytosolic protein by single chain antibody and use thereof |
| 02/22/2007 | WO2007020918A1 Analyte collection chip |
| 02/22/2007 | WO2007020853A1 Method for identifying target protein of agent and method for screening therapeutic agent for diabetes using target protein |
| 02/22/2007 | WO2007020847A1 Method for producing cdna and rna chains and nucleotide-immobilized support |
| 02/22/2007 | WO2007020675A1 Method and apparatus for measuring bod |
| 02/22/2007 | WO2007020522A2 Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type |
| 02/22/2007 | WO2007020482A1 Method and device for examination of dried body fluids |
| 02/22/2007 | WO2007020453A2 Peptide / protein identification using photoreactive carriers for the immobilisation of the ligands |
| 02/22/2007 | WO2007020435A1 Apparatus and method for determining mechanical properties of cement for a well bore |
| 02/22/2007 | WO2007020410A1 Detection of ammonia by electrodes comprising glassy carbon or boron-doped diamond |
| 02/22/2007 | WO2007020405A2 Integrin i-domain binding peptides |
| 02/22/2007 | WO2007020357A2 Method for carrying out homogeneous phase detection, in particular, for detecting the progesterone in the milk of a mammal and corresponding kit |
| 02/22/2007 | WO2007020263A1 Method and device for measuring a state of a liquid |
| 02/22/2007 | WO2007019899A2 Method for predicting the response to a treatment with a her dimerization inhibitor |
| 02/22/2007 | WO2007019875A1 Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
| 02/22/2007 | WO2007019704A1 Sample holder for dynamic light scattering |
| 02/22/2007 | WO2007001895A3 Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
| 02/22/2007 | WO2007001264A3 Method of making recombinant human antibodies for use in biosensor technology |
| 02/22/2007 | WO2006131562A3 Diagnostic and therapeutic target cdc2l6 gene and proteins for neurodegenerative diseases |
| 02/22/2007 | WO2006130736A3 High quantum yield acridinium compounds and their uses in improving assay sensitivity |